These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122. Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections. Le T; Nang SC; Zhao J; Yu HH; Li J; Gill JJ; Liu M; Aslam S Antimicrob Agents Chemother; 2023 Apr; 67(4):e0003723. PubMed ID: 36975787 [TBL] [Abstract][Full Text] [Related]
123. Effect of Carbapenem-Resistant Zheng MM; Guo MX; Shang LM; Zhang J; Lin J; Tian Y; Cui XL; Zhu YC Infect Drug Resist; 2022; 15():6471-6483. PubMed ID: 36353378 [TBL] [Abstract][Full Text] [Related]
124. Clinical outcomes associated with carbapenem resistant Klebsiella pneumoniae (CRKP) in abdominal solid organ transplant (SOT) recipients. Bias TE; Malat GE; Lee DH; Sharma A; Doyle AM Infect Dis (Lond); 2018 Jan; 50(1):67-70. PubMed ID: 28714754 [No Abstract] [Full Text] [Related]
125. Graphene oxide as an efficient antimicrobial nanomaterial for eradicating multi-drug resistant bacteria in vitro and in vivo. Wu X; Tan S; Xing Y; Pu Q; Wu M; Zhao JX Colloids Surf B Biointerfaces; 2017 Sep; 157():1-9. PubMed ID: 28554055 [TBL] [Abstract][Full Text] [Related]
126. Systematic Review and Meta-analysis on Extended-Spectrum β-lactamases Producing Shyaula M; Khadka C; Dawadi P; Banjara MR Microbiol Insights; 2023; 16():11786361221145179. PubMed ID: 36655025 [TBL] [Abstract][Full Text] [Related]
128. Epidemiology, Drug Resistance, and Risk Factors for Mortality Among Hematopoietic Stem Cell Transplantation Recipients with Hospital-Acquired Liu YF; Liu Y; Chen X; Jia Y Infect Drug Resist; 2022; 15():5011-5021. PubMed ID: 36065276 [TBL] [Abstract][Full Text] [Related]
129. Antimicrobial resistance and risk factors for mortality of pneumonia caused by Liu B; Yi H; Fang J; Han L; Zhou M; Guo Y Infect Drug Resist; 2019; 12():1089-1098. PubMed ID: 31123410 [No Abstract] [Full Text] [Related]
130. Distribution and resistance of pathogens in infected patients within 1 year after heart transplantation. Zhou Y; Cai J; Wang X; Du S; Zhang J Int J Infect Dis; 2021 Feb; 103():132-137. PubMed ID: 33212254 [TBL] [Abstract][Full Text] [Related]
131. Characteristics of Immunocytes and Cytokines in Patients with Bloodstream Infections Caused by Carbapenem-Resistant Guo W; Lian X; Li H; Jiang L; Chen Y; Shen P; Yu W Infect Drug Resist; 2024; 17():719-725. PubMed ID: 38410794 [TBL] [Abstract][Full Text] [Related]
132. Clinical epidemiology and outcomes of biliary tract infections caused by Li L; Zhu C; Huang H Ann Transl Med; 2019 Jul; 7(14):304. PubMed ID: 31475174 [TBL] [Abstract][Full Text] [Related]
133. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Carrion AF Liver Transpl; 2016 May; 22(5):698-9. PubMed ID: 26849961 [No Abstract] [Full Text] [Related]
134. Nontoxic Three-Part Combination Local Wound Therapy to Eradicate Carbapenem-Resistant Klebsiella pneumoniae. Kim N; Murphy M; Choudry U Adv Skin Wound Care; 2018 Nov; 31(11):521-523. PubMed ID: 30335644 [TBL] [Abstract][Full Text] [Related]
135. Fatal Donor-Derived Carbapenem-Resistant Varotti G; Dodi F; Marchese A; Terulla A; Bertocchi M; Fontana I Case Rep Transplant; 2016; 2016():7920951. PubMed ID: 27822401 [TBL] [Abstract][Full Text] [Related]
136. Radiation exposure and attributed cancer risk following lung transplantation. Rosengarten D; Raviv Y; Rusanov V; Moreh-Rahav O; Fruchter O; Allen AM; Kramer MR Clin Transplant; 2014 Mar; 28(3):324-9. PubMed ID: 24506701 [TBL] [Abstract][Full Text] [Related]
137. Hypermucoviscous Klebsiella syndrome it's in the community! Sayeed MA; Latif N; Mahmood SF J Pak Med Assoc; 2017 Dec; 67(12):1930-1932. PubMed ID: 29256546 [TBL] [Abstract][Full Text] [Related]
138. A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model. Tan S; Gan C; Li R; Ye Y; Zhang S; Wu X; Yang YY; Fan W; Wu M Int J Nanomedicine; 2015; 10():1045-59. PubMed ID: 25709431 [TBL] [Abstract][Full Text] [Related]
139. Risk Factors and Outcomes of Gavriilaki E; Sakellari I; Chatzikonstantinou T; Mallouri D; Batsis I; Katsifa E; Papadimitriou S; Panteliadou A; Baldoumi E; Demosthenous C; Bousiou Z; Constantinou V; Sotiropoulos D; Anagnostopoulos A Front Med (Lausanne); 2020; 7():608165. PubMed ID: 33614674 [No Abstract] [Full Text] [Related]
140. Determinants of pre-transplantation pectoralis muscle area (PMA) and post-transplantation change in PMA in lung transplant recipients. Hoang V; Li GW; Kao CC; Dronavalli G; Parulekar AD Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]